PureTech Health Shares Outstanding History (PRTC)
PureTech Health reported 241.7M shares outstanding at the end of fiscal 2025.
View full PureTech Health company overviewPureTech Health annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 241.7M | 2.3M | +0.95% |
| 2024 | 2024-12-31 | 239.4M | −32.4M | −11.93% |
| 2023 | 2023-12-31 | 271.9M | −6.7M | −2.41% |
| 2022 | 2022-12-31 | 278.6M | −9.2M | −3.21% |
| 2021 | 2021-12-31 | 287.8M | 1.9M | +0.67% |
| 2020 | 2020-12-31 | 285.9M | — | — |
PureTech Health quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 241.7M | 2.3M | +0.95% |
| Q2 2025 | 2025-06-30 | 240.3M | — | — |
| Q4 2024 | 2024-12-31 | 239.4M | −32.4M | −11.93% |
| Q4 2023 | 2023-12-31 | 271.9M | −6.7M | −2.41% |
| Q4 2022 | 2022-12-31 | 278.6M | −9.2M | −3.21% |
| Q4 2021 | 2021-12-31 | 287.8M | 1.9M | +0.67% |
| Q4 2020 | 2020-12-31 | 285.9M | 0 | 0.00% |
| Q4 2019 | 2019-12-31 | 285.9M | — | — |
PureTech Health Share Buyback History
A share buyback, also called a stock repurchase, is when a company uses cash to buy its own shares. PureTech Health share buyback history shows the reported cash used for repurchases. Buybacks can reduce shares outstanding, but issuance, stock-based compensation, acquisitions, and stock splits can change the share count separately.
PureTech Health used $2.1M to repurchase common stock in fy 2025. Across the latest 4 reported fiscal years, total share repurchases were $53.0M.
| Fiscal year | Period ended | Share repurchases |
|---|---|---|
| 2025 | 2025-12-31 | $2.1M |
| 2024 | 2024-12-31 | $4.8M |
| 2023 | 2023-12-31 | $19.6M |
| 2022 | 2022-12-31 | $26.5M |
TickerStat uses SEC-reported cash payments for common-stock repurchases. The amounts describe capital returned through buybacks; they are not a forecast or a measure of the number of shares retired.
PureTech Health shares outstanding trends
Over the last five fiscal years, PureTech Health's shares outstanding moved from 285.9M to 241.7M, a change of −44.2M. The latest reported quarter, Q4 2025, shows 241.7M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PureTech Health source filings ↗